Clinical Trial Update: ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of ZN-c3 combined with carboplatin and pembrolizumab for metastatic triple-negative breast cancer, currently listed as active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-negative Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pembrolizumab (pembrolizumab)
• ZN-c3

Snippet

Sponsor: Filipa Lynce, MD | Conditions: Breast Cancer, Breast Cancer Female | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING